Insider filing · CYTK
Wendall Wierenga
Director
profile →
Cytokinetics, Incorporated
CYTK · Healthcare · 121 filings in 24 months
ticker →
Wendall Wierenga sold $769K of Cytokinetics (CYTK)
Executed Apr 21 2025, disclosed Apr 21 2025, the same day.
Value, as filed
$769K
20,000 sh × $38.46
Executed
Apr 21 2025
the trade date, as filed
Disclosed
Apr 21 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
WWWendall Wierenga (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $769K of CYTK (20,000 sh × $38.46, as filed), executed Apr 21 2025.
The name
CYTKHealthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Wendall Wierenga in CYTK
CYTKSALE
Cytokinetics, Incorporated
$233K4,452 sh × $52.25
Exec Oct 28 2024
Filed Oct 31 2024 · 5:30 PM ET †